Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Primary Care

What Kind of Doctor Treats Cushing Disease? Care Team

At a Glance

A general endocrinologist can start a Cushing disease evaluation, but conflicting tests, an unclear MRI, or possible surgery warrant a neuroendocrinologist and multidisciplinary pituitary center with experienced imaging and surgical teams.

If you are being evaluated for Cushing disease, your care journey will likely involve several types of doctors. While a primary care physician or a general endocrinologist can appropriately begin your evaluation and order initial screening tests, Cushing disease is a rare and complex condition. If your test results are conflicting, your MRI is inconclusive, or you are a candidate for surgery, it is highly recommended to seek care from a neuroendocrinologist at a multidisciplinary pituitary center [1][2].

Cushing syndrome is a broad term for having too much cortisol in your body, whereas Cushing disease specifically means the excess is caused by a tumor in the pituitary gland. Diagnosing and treating this specific cause can be challenging even for experienced clinicians because symptoms overlap with many common conditions. A specialized pituitary team—which includes neuroendocrinologists, specialized neuroradiologists, and high-volume pituitary neurosurgeons—can provide the exact expertise needed to navigate difficult testing, locate the tumor, and safely perform surgery [1].

The Challenge of Cyclical Testing

Diagnosing Cushing disease requires careful biochemical testing. The pituitary tumor (called a corticotroph adenoma) produces excess adrenocorticotropic hormone (ACTH), which in turn signals your adrenal glands to overproduce cortisol.

In some patients, the tumor does not secrete ACTH constantly. Instead, hormone levels can fluctuate in what is known as cyclic Cushing syndrome [3]. Because cortisol can alternate between high peaks and normal ranges, a single normal test result does not always rule out the disease if clinical suspicion remains high [4].

However, symptoms alone are not a reliable way to time these tests. An endocrinologist with pituitary expertise will know how to perform longitudinal testing—gathering multiple late-night saliva or 24-hour urine samples over time—to accurately capture the periods of excess cortisol [4][3]. They also carefully review your medications (including steroid inhalers or creams) and other physiological conditions to rule out factors that can falsely elevate cortisol, preventing a misdiagnosis [5].

Reading the “Invisible” on MRI

The tumors that cause Cushing disease are notorious for being incredibly small. Depending on the imaging technique and the specific patient, conventional MRI scans can fail to detect the tumor in a substantial minority of patients—sometimes missing up to 25% to 40% of small lesions [4][6]. A radiologist might read a scan as normal because the tumor is less than a few millimeters wide, or they might flag an incidental lesion that is completely unrelated to your disease [4][7].

At a specialized center, dedicated neuroradiologists use advanced, high-resolution MRI techniques specifically designed to look for tiny pituitary lesions.

If your biochemical tests confirm you have an ACTH-dependent form of Cushing’s but your MRI is negative or inconclusive, a specialist may discuss an invasive catheter procedure called inferior petrosal sinus sampling (IPSS) [8]. IPSS measures hormone levels in the veins draining the pituitary gland to help prove whether the excess ACTH is coming from the pituitary or from an ectopic (non-pituitary) tumor elsewhere in the body [8][9]. Because IPSS carries procedural risks like bleeding and clotting, it is not used for every patient and should be performed by an experienced interventional team only after careful consideration of your lab results.

The Importance of a High-Volume Surgeon

If you need transsphenoidal surgery (surgery through the nose) to remove the pituitary tumor, the experience of your surgeon and the hospital team is critical. The pituitary gland sits deep at the base of the brain, surrounded by vital nerves and blood vessels.

Research shows that patients treated by experienced surgeons at specialized centers have initial remission rates (where cortisol returns to an appropriate range after treatment) of approximately 88% to 90% [10][11]. However, these rates depend heavily on the size and visibility of the tumor [10]. Higher surgical volume is also associated with shorter hospital stays and fewer postoperative complications, such as abnormal sodium levels or cerebrospinal fluid leaks [12].

It is also important to know that initial remission is not always a permanent cure. Patients face a lifelong risk of recurrence, as well as the potential need for temporary or ongoing cortisol replacement while their adrenal glands recover after surgery [11][13]. A specialized center provides comprehensive, long-term clinical and biochemical monitoring to manage these postoperative needs and catch any recurrences early [11][14].

Common questions in this guide

Which specialist should I see first for suspected Cushing disease?
A primary care clinician or general endocrinologist can start the evaluation and order initial screening tests. If results conflict, an MRI is unclear, or surgery may be needed, a neuroendocrinologist at a multidisciplinary pituitary center is often the most appropriate next step.
What does a neuroendocrinologist do for Cushing disease?
A neuroendocrinologist specializes in hormone disorders involving the pituitary and helps confirm whether cortisol excess is coming from a pituitary tumor. They can coordinate repeated hormone testing, review medicines that may affect results, and work with imaging specialists and surgeons.
Why is a specialized pituitary center important?
Cushing disease tumors can be only a few millimeters and may be missed or confused with an unrelated finding on a routine MRI. A specialized center brings together pituitary hormone experts, dedicated neuroradiologists, and experienced pituitary neurosurgeons for diagnosis, surgery, and follow-up.
What happens if my MRI does not show a pituitary tumor?
If biochemical testing confirms ACTH-dependent Cushing syndrome but the MRI is negative or uncertain, a specialist may consider inferior petrosal sinus sampling, or IPSS, to help identify the source of ACTH. Because IPSS is invasive and can cause bleeding or clotting complications, it should be recommended only when appropriate and performed by an experienced team.
Can one normal cortisol test rule out Cushing disease?
Not always, especially when cortisol production is cyclical. A pituitary endocrinologist may collect several late-night saliva or 24-hour urine samples over time and review medicines such as steroid inhalers or creams that can affect results.
What should I ask a pituitary surgeon before treatment?
Ask how many Cushing disease patients the team treats each year, the surgeon's remission and complication rates, how remission is defined, and how recurrence will be monitored. Also ask whether you might need temporary or ongoing cortisol replacement after surgery.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many Cushing disease patients do you evaluate and treat annually, and what are the surgeon's specific remission and complication rates?
  2. 2.How do you define 'remission', and what is the long-term follow-up plan to monitor for recurrence?
  3. 3.Which specific tests will establish if I have endogenous hypercortisolism, and could any of my current medications affect these results?
  4. 4.Has my MRI been reviewed using an appropriate pituitary protocol by a dedicated neuroradiologist?
  5. 5.If IPSS is proposed, why is it indicated in my specific case, what are the risks, and who performs the procedure?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome.

    Senanayake R, Gillett D, MacFarlane J, et al.

    Best practice & research. Clinical endocrinology & metabolism 2021; (35(1)):101513 doi:10.1016/j.beem.2021.101513.

    PMID: 34045044
  2. 2

    The role of inferior petrosal sinus sampling in ACTH-dependent Cushing's syndrome: review and joint opinion statement by members of the Italian Society for Endocrinology, Italian Society for Neurosurgery, and Italian Society for Neuroradiology.

    Pecori Giraldi F, Cavallo LM, Tortora F, et al.

    Neurosurgical focus 2015; (38(2)):E5 doi:10.3171/2014.11.FOCUS14766.

    PMID: 25639323
  3. 3

    Cyclic Cushing's Syndrome - A Diagnostic Challenge.

    Świątkowska-Stodulska R, Berlińska A, Stefańska K, et al.

    Frontiers in endocrinology 2021; (12()):658429 doi:10.3389/fendo.2021.658429.

    PMID: 33967962
  4. 4

    An individualized approach to the management of Cushing disease.

    Fleseriu M, Varlamov EV, Hinojosa-Amaya JM, et al.

    Nature reviews. Endocrinology 2023; (19(10)):581-599 doi:10.1038/s41574-023-00868-7.

    PMID: 37537306
  5. 5

    Pitfalls in the diagnosis and management of Cushing's syndrome.

    Bansal V, El Asmar N, Selman WR, Arafah BM

    Neurosurgical focus 2015; (38(2)):E4 doi:10.3171/2014.11.FOCUS14704.

    PMID: 25639322
  6. 6

    Emerging diagnostic methods and imaging modalities in cushing's syndrome.

    Wright K, van Rossum EFC, Zan E, et al.

    Frontiers in endocrinology 2023; (14()):1230447 doi:10.3389/fendo.2023.1230447.

    PMID: 37560300
  7. 7

    Adrenocortical carcinoma masquerading as Cushing's disease.

    Jarial KD, Walia R, Kumar S, Bhansali A

    BMJ case reports 2017; (2017()) doi:10.1136/bcr-2016-217519.

    PMID: 28356253
  8. 8

    Consensus Guidelines on Inferior Petrosal Sinus Sampling: A Guideline From the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee.

    Siddiq F, Brooks H, Demirtas E, et al.

    Stroke (Hoboken, N.J.) 2026; (6(3)):e002309 doi:10.1161/SVIN.125.002309.

    PMID: 42088331
  9. 9

    The role of bilateral inferior petrosal sinus sampling in determining the preoperative localization of ACTH-secreting pituitary microadenomas in Cushing's disease: Experience of a tertiary center.

    Bestepe N, Ozdemir D, Polat B, et al.

    Clinical neurology and neurosurgery 2021; (207()):106724 doi:10.1016/j.clineuro.2021.106724.

    PMID: 34102422
  10. 10

    Results and predictors of outcome of endoscopic endonasal surgery in Cushing's disease: 20-year experience of an Italian referral Pituitary Center.

    Guaraldi F, Zoli M, Asioli S, et al.

    Journal of endocrinological investigation 2020; (43(10)):1463-1471 doi:10.1007/s40618-020-01225-5.

    PMID: 32215861
  11. 11

    Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience.

    Johnston PC, Kennedy L, Hamrahian AH, et al.

    Pituitary 2017; (20(4)):430-440 doi:10.1007/s11102-017-0802-1.

    PMID: 28265841
  12. 12

    The socioeconomic determinants for transsphenoidal pituitary surgery: a review of New York State from 1995 to 2015.

    McKee S, Yang A, Kidwai S, et al.

    International forum of allergy & rhinology 2018; (8(10)):1145-1156 doi:10.1002/alr.22148.

    PMID: 30007017
  13. 13

    Recovery of Adrenal Function after Pituitary Surgery in Patients with Cushing Disease: Persistent Remission or Recurrence?

    Serban AL, Sala E, Carosi G, et al.

    Neuroendocrinology 2019; (108(3)):211-218 doi:10.1159/000496846.

    PMID: 30636245
  14. 14

    Therapeutic options after surgical failure in Cushing's disease: A critical review.

    Rubinstein G, Osswald A, Zopp S, et al.

    Best practice & research. Clinical endocrinology & metabolism 2019; (33(2)):101270 doi:10.1016/j.beem.2019.04.004.

    PMID: 31036383

This page is for informational purposes only and does not constitute medical advice about Cushing disease. Your endocrinologist or pituitary care team can recommend the right specialists, tests, and treatment plan for your situation.

Get notified when new evidence is published on Cushing disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.